- Exchange: Stuttgart
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Aoxing Pharmaceutical Co Inc
+ Add to Watchlist5CA:GR
0.147 EUR 0.065 79.27%As of 02:02:21 ET on 05/24/2013.
Snapshot for Aoxing Pharmaceutical Co Inc (5CA)
| Open: | 0.080 | Day's Range: | 0.080 - 0.147 | Volume: | 0 |
|---|---|---|---|---|---|
| Previous Close: | 0.082 | 52wk Range: | 0.046 - 0.304 | 1-Yr Rtn: | -1.34% |
Key Statistics for 5CA
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(06/2013) | - |
| Relative P/E vs. DAX | - |
| Earnings Per Share (ttm) | - |
| Est. EPS (06/2013) | - |
| Est. PEG Ratio | - |
| Market Cap (M EUR) | 0.00 |
| Shares Outstanding (M) | 0.00 |
| 30 Day Average Volume | 0 |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 10/14/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for 5CA
Company Profile & Key Executives for 5CA
Aoxing Pharmaceutical Company Inc., is a specialty pharmaceutical company. The Company specializes in the research, development, manufacturing, and distribution of a variety of narcotics and pain-management products.
| Zhenjiang YueChairman/CEO | Guoan ZhangActing CFO |
| Guirong ZhouPresident:Research & Dev | Vicky ZhangInvestor Relations |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
5CA News
-
Industry News
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page